Beijing Hotgen Biotech Co Ltd (688068) Stock Price & News

Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification. Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia

About Beijing Hotgen Biotech Co Ltd

CEO-

Employees1,04 миң

Founded2005-ж., 23-июн.

Headquarters-

SectorHealth care

Websitehotgen.com.cn

All values in CNY	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	105,80 млн	95,17 млн	116,03 млн	151,72 млн
Cost of goods sold	49,91 млн	40,31 млн	55,11 млн	36,50 млн
Cost of revenue	49,91 млн	40,31 млн	55,11 млн	36,50 млн
Research and development expenses	19,65 млн	94,81 млн	49,10 млн	46,03 млн
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	83,78 млн	99,31 млн	97,60 млн	127,34 млн
Operating expense	98,59 млн	204,82 млн	143,51 млн	186,68 млн
Total operating expenses	148,50 млн	245,13 млн	198,62 млн	223,17 млн
Operating income	-42,70 млн	-149,96 млн	-82,59 млн	-71,46 млн
Other non operating income	-273,76 миң	2,19 млн	-2,39 млн	2,09 млн
EBT including unusual items	-20,92 млн	-155,14 млн	-82,67 млн	-76,94 млн
EBT excluding unusual items	-28,82 млн	-122,01 млн	-69,59 млн	-76,99 млн
Income tax expense	4,59 млн	-6,98 млн	-5,78 миң	-796,34 миң
Effective tax rate	-21,96%	4,50%	0,01%	1,03%
Other operating expenses	-5,37 млн	6,99 млн	-2,96 млн	3,17 млн
Net income	-24,96 млн	-107,09 млн	-68,06 млн	-58,07 млн
Net profit margin	-23,59%	-112,52%	-58,66%	-38,27%
Earnings per share	-	-	-	-
Interest and investment income	14,98 млн	35,99 млн	15,44 млн	3,94 млн
Interest expense	-289,66 миң	-7,96 млн	-46,88 миң	-7,63 млн
Net interest expenses	14,69 млн	28,03 млн	15,39 млн	-3,69 млн
Depreciation and amortization charges	-	-	-	-
EBITDA	-21,62 млн	-129,90 млн	-62,53 млн	-53,46 млн
Gain or loss from assets sale	601,43 миң	-579,43 миң	-	6,83 миң

Ask anything